shot-button
Ganesh Chaturthi Ganesh Chaturthi
Home > News > India News > Article > India will be able to end TB by 2025 Harsh Vardhan

India will be able to end TB by 2025: Harsh Vardhan

Updated on: 24 September,2020 08:48 AM IST  |  New Delhi
ANI |

He pointed out that poverty is a powerful determinant of tuberculosis and undernutrition an important risk factor of developing active TB disease.

India will be able to end TB by 2025: Harsh Vardhan

Union Health Minister Dr Harsh Vardhan.Picture/Twitter Dr Harsh Vardhan

Under Prime Minister Narendra Modi, India has accorded high priority for ending tuberculosis by 2025, five years ahead of the Sustainable Development Goals (SDG), said Dr Harsh Vardhan, Union Minister for Health and Family Welfare.


Addressing ministers of Member Nations of WHO, Heads, and Representatives of UN Agencies and partner organisations, Dr Vardhan said, "In India, under the guidance of Prime Minister, Narendra Modi, India has accorded high priority for ending tuberculosis by 2025, five years ahead of the Sustainable Development Goals (SDG)."


"Tuberculosis has been in existence since time immemorial and continues to remain a major global public health problem. Despite the progress made over the last decade, TB remains the leading infectious killer disease worldwide," he said.


Read: Mumbai: Massive tumour taken out of 55-year-old's abdomen

Lauding India's efforts towards eradication of TB, Harsh Vardhan said, "With bold and innovative policies supported by commensurate resources, India has taken several critical steps towards ending TB. We have significantly reduced the number of missing TB patients from one million in 2016 to less than 0.5 million in 2019, with 2.4 million cases notified during the year. Most importantly, a third of these notifications were contributed by the private sector. With the scale-up of rapid molecular diagnostics in every district of the country, we were able to identify over 66,000 drug-resistant TB patients in 2019."

He pointed out that poverty is a powerful determinant of tuberculosis and undernutrition an important risk factor of developing active TB disease. "To address this, we are providing cash incentives through Direct Benefit Transfers for nutritional support and since April 2018, Rs 7.9 billion (around USD 110 million) have been distributed to over 3 million beneficiaries. Affordable and quality TB care is a priority for our Government", he stated.

The Minister further spoke about India's fight against COVID-19 and said: "We reached a historic low in the month of April with lockdown in full force, but through sustained efforts, we have managed an increase of 43 per cent in May and another 25 per cent in June."

To mitigate the impact, the government has been issuing constant advisories to the States to ensure convergence of TB case finding with COVID-19 efforts, he said adding that "we have initiated bi-directional screening among TB and COVID patients, and screening for TB among influenza like illness (ILI) and severe acute respiratory infections (SARI)."

Catch up on all the latest Crime, National, International and Hatke news here. Also download the new mid-day Android and iOS apps to get latest updates.

Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK